Literature DB >> 24570937

Comparison of high-intensity focused ultrasound therapy and radiofrequency ablation for recurrent hepatocellular carcinoma.

Hiroki Nishikawa1, Yukio Osaki1.   

Abstract

Entities:  

Year:  2013        PMID： 24570937      PMCID： PMC3924674          DOI： 10.3978/j.issn.2304-3881.2013.03.01

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  20 in total

Review 1.  Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma.

Authors:  Hua-Ping Shen; Jian-Ping Gong; Guo-Qing Zuo
Journal:  Am Surg       Date:  2011-11       Impact factor: 0.688

Review 2.  Loco-regional treatment of hepatocellular carcinoma.

Authors:  Riccardo Lencioni
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

Review 3.  Management of HCC.

Authors:  Carlos Rodríguez de Lope; Silvia Tremosini; Alejandro Forner; María Reig; Jordi Bruix
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

4.  High-intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations.

Authors:  Franco Orsi; Lian Zhang; Paolo Arnone; Gianluigi Orgera; Guido Bonomo; Paolo Della Vigna; Lorenzo Monfardini; Kun Zhou; Wenzhi Chen; Zhibiao Wang; Umberto Veronesi
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

5.  A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Authors:  Wei-Ping Zhou; Eric C H Lai; Ai-Jun Li; Si-Yuan Fu; Jian-Ping Zhou; Ze-Ya Pan; Wan Yee Lau; Meng-Chao Wu
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

6.  A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

Authors:  Shuichiro Shiina; Takuma Teratani; Shuntaro Obi; Shinpei Sato; Ryosuke Tateishi; Tomonori Fujishima; Takashi Ishikawa; Yukihiro Koike; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

Review 7.  Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010.

Authors:  Masatoshi Kudo
Journal:  Oncology       Date:  2010-07-08       Impact factor: 2.935

8.  Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.

Authors:  Chuanxing Li; Weidong Zhang; Rong Zhang; Liang Zhang; Peihong Wu; Fujun Zhang
Journal:  Eur J Cancer       Date:  2010-07-19       Impact factor: 9.162

9.  Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.

Authors:  Hiroki Nishikawa; Akira Arimoto; Tomoko Wakasa; Ryuichi Kita; Toru Kimura; Yukio Osaki
Journal:  Int J Oncol       Date:  2012-11-21       Impact factor: 5.650

10.  Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?

Authors:  Beatrijs A Seinstra; Otto M van Delden; Karel J van Erpecum; Richard van Hillegersberg; Willem P Th M Mali; Maurice A A J van den Bosch
Journal:  Insights Imaging       Date:  2010-06-01
View more
  3 in total

1.  Clinical diagnosis and treatment of alpha-fetoprotein-negative small hepatic lesions.

Authors:  Yiyao Xu; Xin Lu; Yilei Mao; Xinting Sang; Haitao Zhao; Shunda Du; Haifeng Xu; Yongliang Sun; Huayu Yang; Tianyi Chi; Zhiying Yang; Shouxian Zhong; Jiefu Huang
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

2.  Improving the heating efficiency of high intensity focused ultrasound ablation through the use of phase change nanodroplets and multifocus sonication.

Authors:  Aparna Singh; A Gloria Nyankima; M Anthony Phipps; Vandiver Chaplin; Paul A Dayton; Charles Caskey
Journal:  Phys Med Biol       Date:  2020-10-12       Impact factor: 3.609

3.  Effectiveness and safety of focused ultrasound ablation surgery compared with radiofrequency ablation in primary hepatocellular carcinoma treatment: a meta-analysis.

Authors:  Jian-Ying Zhang; Long Chen; Rong Ma; Chun-Mu Miao; Yun-Bing Wang
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.